# Healthpeak Properties, Inc. (DOC) FY2026 Q2 Statement of Cash Flows - Company: Healthpeak Properties, Inc. (DOC) - Period: 2026-04-01 to 2026-06-30 - Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001628280-26-053373 - Page: https://plicit.ai/financials/doc/fy2026-q2-cash-flow - Chart image: https://plicit.ai/charts/doc-fy2026-q2-cash-flow-sankey.png ## Chart details Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it. - **Beginning cash on Mar 31, 2026**: 1,265,909,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations - **Operating activities**: 361,100,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Depreciation and amortization of real estate, in-place lease, and other intangibles), so Depreciation and amortization of real estate, in-place lease, and other intangibles cannot be separated for this quarter. It may combine inflows and outflows. - **Net income (loss)**: 63,241,000 US dollars - **Stock-based compensation amortization expense**: 4,806,000 US dollars - **Stock-based compensation issued as part of initial public offering of Janus Living, Inc.**: 0 US dollars - **Amortization of deferred financing costs and debt discounts (premiums)**: 8,901,000 US dollars - **Straight-line rents**: negative 12,183,000 US dollars - **Amortization of above (below) market lease intangibles**: negative 6,308,000 US dollars - **Amortization of non-refundable entrance fees**: negative 27,807,000 US dollars - **Equity loss (income) from unconsolidated joint ventures**: negative 2,509,000 US dollars - **Distributions of earnings from unconsolidated joint ventures**: 654,000 US dollars - **Deferred income tax expense (benefit)**: negative 2,011,000 US dollars - **Impairments and loan loss reserves (recoveries), net**: negative 1,479,000 US dollars - **Loss (gain) on debt extinguishments**: 0 US dollars - **Loss (gain) on sales of real estate, net**: negative 9,988,000 US dollars - **Loss (gain) upon change of control, net**: negative 226,000 US dollars - **Casualty-related loss (recoveries), net**: negative 5,507,000 US dollars - **Other non-cash items**: negative 10,977,000 US dollars - **Decrease (increase) in accounts receivable and other assets**: 26,241,000 US dollars - **Increase (decrease) in accounts payable, accrued liabilities, and other liabilities**: 10,856,000 US dollars - **Increase (decrease) in deferred revenue**: 42,006,000 US dollars - **Remaining operating cash flows, net (calculated)**: 283,390,000 US dollars - **Investing activities**: 132,631,000 US dollars. Net cash provided. - **Acquisitions of real estate**: negative 114,489,000 US dollars - **Joint venture buyout, net**: negative 4,454,000 US dollars - **Development, redevelopment, and other major improvements of real estate**: negative 157,026,000 US dollars - **Leasing costs, tenant improvements, and recurring capital expenditures**: negative 42,105,000 US dollars - **Proceeds from sales of real estate, net**: 56,601,000 US dollars - **Proceeds from the BX JV I and II transaction, net**: 0 US dollars - **Investments in unconsolidated joint ventures**: negative 761,000 US dollars - **Distributions in excess of earnings from unconsolidated joint ventures**: 7,032,000 US dollars - **Proceeds from insurance recovery**: 7,131,000 US dollars - **Proceeds from sales/principal repayments on loans receivable and other**: 398,799,000 US dollars - **Investments in loans receivable and other**: negative 18,097,000 US dollars - **Financing activities**: negative 40,955,000 US dollars. Net cash used. - **Borrowings under bank line of credit and commercial paper**: 7,854,200,000 US dollars - **Repayments under bank line of credit and commercial paper**: negative 8,109,615,000 US dollars - **Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt**: 0 US dollars - **Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt**: negative 142,321,000 US dollars - **Payments for debt extinguishment and deferred financing costs**: negative 1,063,000 US dollars - **Issuance of common stock, net of offering costs**: 636,000 US dollars - **Repurchase of common stock**: negative 100,187,000 US dollars - **Dividends paid on common stock**: negative 210,256,000 US dollars - **Distributions to and redemption of noncontrolling interests**: negative 22,387,000 US dollars - **Proceeds from Janus Living public offerings, net of underwriting fees**: 691,198,000 US dollars - **Contributions from and issuance of noncontrolling interests**: 760,000 US dollars - **Noncontrolling interest issuance costs**: negative 1,920,000 US dollars - **Operating adjustment reconciliation**: 376,854,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow. - **financing gross reconciliation**: 8,587,749,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use. - **investing gross reconciliation**: 469,563,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use. - **Exchange-rate effect**: 0 US dollars - **Ending cash on Jun 30, 2026**: 1,718,685,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations - **Cash sources and uses**: 1,759,640,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash. - **Net cash change**: 452,776,000 US dollars. Ending cash minus beginning cash. - **Cash flow / Net income**: 5.71×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio. ### Chart connections - Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash. - Financing contributions meet at a reconciliation junction before connecting to the net cash total. - Investing contributions meet at a reconciliation junction before connecting to the net cash total. - Operating reconciliation adjustments are not all independent cash receipts. - Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $297.86M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts. - Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment. - The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.